The CYTK chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the CYTK chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The CYTK stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View CYTK Detailed Price Forecast - CNN Money||View CYTK Detailed Summary - Google Finance|
|View CYTK Detailed Summary - Yahoo! Finance||View CYTK Stock Research & Analysis - Zacks.com|
|View CYTK Trends & Analysis - Trade-Ideas||View CYTK Major Holders - Barrons|
|View CYTK Call Transcripts - NASDAQ||View CYTK Breaking News & Analysis - Seeking Alpha|
|View CYTK Annual Report - CompanySpotlight.com||View CYTK OTC Short Report - OTCShortReport.com|
|View CYTK Fundamentals - TradeKing||View CYTK SEC Filings - Bar Chart|
|View Historical Prices for CYTK - The WSJ||View Performance/Total Return for CYTK - Morningstar|
|View the Analyst Estimates for CYTK - MarketWatch||View the Earnings History for CYTK - CNBC|
|View the CYTK Earnings - StockMarketWatch||View CYTK Buy or Sell Recommendations - MacroAxis|
|View the CYTK Bullish Patterns - American Bulls||View CYTK Short Pain Metrics - ShortPainBot.com|
|View CYTK Stock Mentions - StockTwits||View CYTK Stock Mentions - PennyStockTweets|
|View CYTK Stock Mentions - Twitter||View CYTK Investment Forum News - Investor Hub|
|View CYTK Stock Mentions - Yahoo! Message Board||View CYTK Stock Mentions - Seeking Alpha|
|View Insider Transactions for CYTK - SECform4.com||View Insider Transactions for CYTK - Insider Cow|
|View CYTK Major Holdings Summary - CNBC||View Insider Disclosure for CYTK - OTC Markets|
|View Insider Transactions for CYTK - Yahoo! Finance||View Institutional Holdings for CYTK - NASDAQ|
|View CYTK Stock Insight & Charts - FinViz.com||View CYTK Investment Charts - StockCharts.com|
|View CYTK Stock Overview & Charts - BarChart||View CYTK User Generated Charts - Trading View|
Cytokinetics Announces New Data Presented at the International Symposium on ALS/MND
Posted on Monday December 10, 2018
SOUTH SAN FRANCISCO, Calif., Dec. 10, 2018 -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that new data were presented at the 29th International Symposium on.
Cytokinetics Announces Initiation of Phase 1 Clinical Trial of CK-3773274, a Cardiac Myosin Inhibitor
Posted on Wednesday December 05, 2018
Cytokinetics, Incorporated (CYTK) today announced the first subject has been dosed in a Phase 1 double-blind, randomized, placebo-controlled, multi-part, single and multiple ascending dose clinical trial of CK-3773274 (CK-274) in healthy adult subjects. CK-274 is a novel cardiac myosin inhibitor, discovered by company scientists, in development for the potential treatment of hypertrophic cardiomyopathy (HCM). “The start of clinical trials for CK-274 marks an important milestone in our continuing innovation of potential sarcomere-directed medicines,” said Fady I. Malik, M.D., Ph.D., Cytokinetics’ Executive Vice President of Research & Development.
Jim Cramer Gives His Opinion On Netflix, Kraft Heinz And More
Posted on Monday December 03, 2018
On CNBC's "Mad Money Lightning Round," Jim Cramer said he isn't a fan of Netflix, Inc. (NASDAQ: NFLX ) because the content isn't as compelling as it once was. He sees it as a good story, but ...
Analysis: Positioning to Benefit within Abeona Therapeutics, Great Lakes Dredge & Dock, Imprimis Pharmaceuticals, Alliant Energy, Cytokinetics, and Aurinia Pharmaceuticals — Research Highlights Growth, Revenue, and Consolidated Results
Posted on Tuesday November 27, 2018
NEW YORK, Nov. 27, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.